Search Results | Showing 41 - 50 of 119 results for "Pharmaceuticals" |
| | | ... ExxonMobil fell by 1.2 per cent and 1.3 per cent respectively, while offshore driller Transocean lost 2.0 per cent. Pharmaceuticals were also weak. Merck lost 1.8 per cent, while biotech companies Amgen and Biogen both fell 1.2 per cent. In the tech ... |
| | | | ... large technology companies based in the United States, such as Cisco. About 15% of the portfolio is allocated in pharmaceuticals, with a focus on "new treatments that could be revolutionary, such as DNA sequencing," Crooke explained, and added that European ... |
| | | | ... issues its quarterly bulletin. In equities news, Myer, Metcash and OrotonGroup issue half year results while Sigma Pharmaceuticals is due to post full year results. And, Medibank Private chief executive George Savvides addresses a CEDA lunch in Melbourne. ... |
| | | | ... Capital's senior client adviser Michael Heffernan. "That's obviously going to set the tone of the overall market." Pharmaceuticals giant CSL and finance group Suncorp both wound back their full year guidance on Wednesday after softer than expected first ... |
| | | | ... $9.545, but Harvey Norman was two cents higher at $3.74. Another company to release financial results was Sigma Pharmaceuticals, which achieved a 38 per cent rise in half year profit. But its shares were 2.5 cents weaker at 80.5 cents. |
| | | | ... more "paid clicks". Drug maker AbbVie sealed a tax-cutting $US54 billion takeover deal with Dublin-based Shire Pharmaceuticals as it plans to switch its tax base to Britain to avoid higher US taxes. AbbVie rose 2.6 per cent. In local economic news on ... |
| | | | ... straight day. But the tech-rich Nasdaq fell 5.33 points, or 0.13 per cent, to 4,242.62. Stocks rose after Valeant Pharmaceuticals raised its bid for Botox-maker Allergan for the second time this week. Valeant rose 1.5, while Allergan jumped 5.7 per cent. ... |
| | | | ... chairman to take up his new role at News Corporation and 21st Century Fox, were down 0.25 cents at 26.25 cents. Pharmaceuticals wholesaler Sigma Pharmaceuticals' shares were up 3.5 cents at 66.5 cents after posting a net profit of $53.5 million for the ... |
| | | | ... was down 26 points at 5,344. Locally, no major economic news is expected on Thursday. In equities news, Sigma Pharmaceuticals is expected to post full year results while Washington H Soul Pattinson and Brickworks are slated to release first half results. ... |
| | | | ... world class companies in sectors that are under-represented on the Australian share market, such as technology, pharmaceuticals, food and beverage, consumer brands, aerospace and luxury goods," he continued. "Many of those companies are wired to the ... |
|
